Terzolo M - Search Results

1

S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study.

Elhassan YS, Altieri B, Berhane S, Cosentini D, Calabrese A, Haissaguerre M, Kastelan D, Fragoso MCBV, Bertherat J, Al Ghuzlan A, Haak H, Boudina M, Canu L, Loli P, Sherlock M, Kimpel O, Laganà M, Sitch AJ, Kroiss M, Arlt W, Terzolo M, Berruti A, Deeks JJ, Libé R, Fassnacht M, Ronchi CL. Elhassan YS, et al. Among authors: terzolo m. Eur J Endocrinol. 2021 Nov 30;186(1):25-36. doi: 10.1530/EJE-21-0510. Eur J Endocrinol. 2021. PMID: 34709200 Free PMC article.

2

Favorable response of metastatic adrenocortical carcinoma to etoposide, adriamycin and cisplatin (EAP) chemotherapy. Report of two cases.

Berruti A, Terzolo M, Paccotti P, Veglio F, Pia A, Dogliotti L, Angeli A. Berruti A, et al. Among authors: terzolo m. Tumori. 1992 Oct 31;78(5):345-8. doi: 10.1177/030089169207800512. Tumori. 1992. PMID: 1494808

3

Melatonin and human cancer.

Dogliotti L, Berruti A, Buniva T, Torta M, Bottini A, Tampellini M, Terzolo M, Faggiuolo R, Angeli A. Dogliotti L, et al. Among authors: terzolo m. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):983-7. doi: 10.1016/0960-0760(90)90454-s. J Steroid Biochem Mol Biol. 1990. PMID: 2285610

4

Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.

Berruti A, Terzolo M, Pia A, Angeli A, Dogliotti L. Berruti A, et al. Among authors: terzolo m. Cancer. 1998 Nov 15;83(10):2194-200. Cancer. 1998. PMID: 9827725 Clinical Trial.

5

Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer.

Terzolo M, Pia A, Berruti A, Osella G, Alì A, Carbone V, Testa E, Dogliotti L, Angeli A. Terzolo M, et al. J Clin Endocrinol Metab. 2000 Jun;85(6):2234-8. doi: 10.1210/jcem.85.6.6619. J Clin Endocrinol Metab. 2000. PMID: 10852456

6

Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial.

Berruti A, Terzolo M, Sperone P, Pia A, Della Casa S, Gross DJ, Carnaghi C, Casali P, Porpiglia F, Mantero F, Reimondo G, Angeli A, Dogliotti L. Berruti A, et al. Among authors: terzolo m. Endocr Relat Cancer. 2005 Sep;12(3):657-66. doi: 10.1677/erc.1.01025. Endocr Relat Cancer. 2005. PMID: 16172198 Clinical Trial.

7

Prevalence of adrenal incidentaloma in a contemporary computerized tomography series.

Bovio S, Cataldi A, Reimondo G, Sperone P, Novello S, Berruti A, Borasio P, Fava C, Dogliotti L, Scagliotti GV, Angeli A, Terzolo M. Bovio S, et al. Among authors: terzolo m. J Endocrinol Invest. 2006 Apr;29(4):298-302. doi: 10.1007/BF03344099. J Endocrinol Invest. 2006. PMID: 16699294

8

Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane.

Sperone P, Berruti A, Gorzegno G, Paccotti P, Terzolo M, Porpiglia F, Angeli A, Dogliotti L. Sperone P, et al. Among authors: terzolo m. J Endocrinol Invest. 2006 Jun;29(6):560-2. doi: 10.1007/BF03344148. J Endocrinol Invest. 2006. PMID: 16840836

9

Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: Diagnostic and prognostic significance in a series of 50 adrenocortical carcinomas.

Volante M, Sperone P, Bollito E, Frangipane E, Rosas R, Daffara F, Terzolo M, Berruti A, Papotti M. Volante M, et al. Among authors: terzolo m. Mod Pathol. 2006 Dec;19(12):1563-9. doi: 10.1038/modpathol.3800683. Epub 2006 Sep 15. Mod Pathol. 2006. PMID: 16980949 Free article.

10

Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors.

Ferrante E, Ferraroni M, Castrignanò T, Menicatti L, Anagni M, Reimondo G, Del Monte P, Bernasconi D, Loli P, Faustini-Fustini M, Borretta G, Terzolo M, Losa M, Morabito A, Spada A, Beck-Peccoz P, Lania AG. Ferrante E, et al. Among authors: terzolo m. Eur J Endocrinol. 2006 Dec;155(6):823-9. doi: 10.1530/eje.1.02298. Eur J Endocrinol. 2006. PMID: 17132751

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

280 results

Search Page